Skip to main content
. 2018 Dec 14;24(4):513–520. doi: 10.1634/theoncologist.2018-0305

Figure 1.

image

Adjuvant transarterial chemoembolization (TACE) on overall survival in prespecified or exploratory subgroups. Odds ratio (OR) of adjuvant TACE on overall survival was significantly different in different tumor size subgroups (OR = 0.60 in tumor size ≤5 cm subgroup and OR = 1.19 in tumor size >5 cm subgroup, p = .006 for interaction). In addition, adjuvant TACE showed consistent protective effect on overall survival in all of the remaining subgroups (all p > .05 for interaction).

Abbreviations: AFP, alpha‐fetoprotein; CI, confidence interval; ES, Edmonson‐Steiner; HbsAg, hepatitis B surface antigen.